Please assess the completion status of the following clinical trial:

Trial Title: Mitral Valve Reconstruction in Chronic Heart Failure (CHF): Identification of Predictors for a Successful Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age \> 18 years old~2. Dilatative Cardiomyopathy with LVEF \< 35%~3. NYHA III oder IV under maximal medical treatment~4. Angiographic and hemodynamic MI \> II° (LAP- mean pressure \> 15-20 mmHg; LA v-wave-oder PCWP v-wave \> 35 mmHg under exercise)~5. Echocardiographic MI \> II°~6. At least 1 hospitalization for heart failure before OP~Exclusion Criteria:~1. Secondary Cardiomyopathy by vitium cordis~2. Planned secondary procedure like CABG, aortic valve surgery, surgery of the tricuspid valve etc~3. Inclusion in another trial~4. Euro-Score \> 30%~5. Former valve operation or CABG

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Surgical mitral valve reconstruction
- 2 (Type: NO_INTERVENTION): conservative treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).